FRATES JAMES M

FRATES JAMES M's trades of Amylyx Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-02 2025-03-31
S Sale
10,896 -3.6%
3.47
USD 37,806 		10,896 -3.6% 3.47 USD 37,806
2024-09-16 2024-09-12
B Purchase
40,000 +20.7%
2.53
USD 101,368 		40,000 +20.7% 2.53 USD 101,368
2024-03-07 2024-03-05
S Sale
1,792 -1.3%
18.73
USD 33,560 		1,792 -1.3% 18.73 USD 33,560
2024-01-11 2024-01-09
S Sale
2,716 -2.4%
16.33
USD 44,347 		2,716 -2.4% 16.33 USD 44,347
2023-05-18 2023-05-16
PS Planned sale
500 -0.9%
27.60
USD 13,800 		500 -0.9% 27.60 USD 13,800
2023-05-18 2023-05-16
PS Planned sale
32,000 -36.3%
26.93
USD 861,651 		32,000 -36.3% 26.93 USD 861,651
2023-03-20 2023-03-16
PS Planned sale
1,704 -53.0%
32.46
USD 55,320 		1,704 -53.0% 32.46 USD 55,320
2023-03-20 2023-03-16
PS Planned sale
30,796 -90.6%
31.86
USD 981,139 		30,796 -90.6% 31.86 USD 981,139
2019-05-06 2019-05-06
PS Planned sale
8,000 -65.4%
162.22
USD 1,297,760 		8,000 -65.4% 162.22 USD 1,297,760
2019-01-24 2019-01-23
PS Planned sale
7,500 -63.9%
134.81
USD 1,011,075 		7,500 -63.9% 134.81 USD 1,011,075
2004-07-02 2004-07-01
US Alkermes Inc (ALKS)
PS Planned sale
2,174 -4.8%
13.41
USD 29,157 		2,174 -4.8% 13.41 USD 29,157
// ... existing code ... // ... rest of the file ...